Also known as Tracleer
Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.Source: Wikipedia
Estimated Total Cost: $5485.41 for an average of 28 days supply
Patients are most commonly prescribed bosentan to treat pulmonary hypertension, coronary atherosclerosis, rabies, and blastomycosis.